 Gernot Kaber
Concepts (290)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyaluronic Acid | 15 | 2024 | 223 | 1.320 |
Why?
| | Hymecromone | 7 | 2024 | 7 | 0.920 |
Why?
| | Pseudomonas Infections | 4 | 2024 | 230 | 0.630 |
Why?
| | Versicans | 4 | 2023 | 9 | 0.600 |
Why?
| | Bacteriophages | 4 | 2023 | 111 | 0.600 |
Why?
| | T-Lymphocytes, Regulatory | 6 | 2024 | 394 | 0.580 |
Why?
| | Extracellular Matrix | 7 | 2024 | 560 | 0.390 |
Why?
| | Islets of Langerhans | 3 | 2025 | 842 | 0.350 |
Why?
| | Cyclooxygenase 2 Inhibitors | 1 | 2011 | 24 | 0.350 |
Why?
| | Lactones | 1 | 2011 | 59 | 0.330 |
Why?
| | Sulfones | 1 | 2011 | 127 | 0.330 |
Why?
| | Immune Tolerance | 3 | 2019 | 381 | 0.320 |
Why?
| | Carbocyanines | 1 | 2009 | 37 | 0.310 |
Why?
| | Wound Infection | 2 | 2022 | 59 | 0.310 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 110 | 0.300 |
Why?
| | Pseudomonas aeruginosa | 4 | 2024 | 391 | 0.290 |
Why?
| | Diabetes Mellitus, Experimental | 3 | 2019 | 185 | 0.280 |
Why?
| | Fluorescent Dyes | 2 | 2010 | 333 | 0.280 |
Why?
| | Fibrinolytic Agents | 1 | 2011 | 290 | 0.280 |
Why?
| | Proteome | 2 | 2010 | 515 | 0.270 |
Why?
| | Aspirin | 1 | 2011 | 402 | 0.270 |
Why?
| | Atherosclerosis | 1 | 2011 | 409 | 0.260 |
Why?
| | Diabetes Mellitus, Type 1 | 7 | 2025 | 3910 | 0.260 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2011 | 496 | 0.260 |
Why?
| | Proteins | 2 | 2010 | 1016 | 0.250 |
Why?
| | Autoimmune Diseases | 3 | 2020 | 465 | 0.250 |
Why?
| | Hyaluronan Receptors | 4 | 2023 | 104 | 0.240 |
Why?
| | Cell Engineering | 1 | 2025 | 14 | 0.230 |
Why?
| | Mice | 20 | 2025 | 18261 | 0.220 |
Why?
| | Animals | 27 | 2025 | 37948 | 0.220 |
Why?
| | Hydrogels | 3 | 2020 | 703 | 0.210 |
Why?
| | Antigens, Neoplasm | 1 | 2025 | 272 | 0.200 |
Why?
| | Alternative Splicing | 2 | 2023 | 247 | 0.200 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2024 | 68 | 0.200 |
Why?
| | Interleukin-2 | 2 | 2024 | 438 | 0.190 |
Why?
| | Longevity | 1 | 2024 | 175 | 0.190 |
Why?
| | Inovirus | 1 | 2022 | 2 | 0.190 |
Why?
| | Organoids | 1 | 2024 | 139 | 0.180 |
Why?
| | Pancreas | 1 | 2025 | 341 | 0.180 |
Why?
| | Mice, Inbred C57BL | 7 | 2024 | 5967 | 0.180 |
Why?
| | Immunotherapy, Adoptive | 1 | 2025 | 339 | 0.180 |
Why?
| | Interferon Type I | 1 | 2022 | 146 | 0.170 |
Why?
| | Cells, Cultured | 8 | 2020 | 4110 | 0.160 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2024 | 294 | 0.160 |
Why?
| | Interleukin-10 | 2 | 2019 | 310 | 0.150 |
Why?
| | Dendritic Cells | 2 | 2020 | 498 | 0.150 |
Why?
| | Protein Isoforms | 3 | 2023 | 396 | 0.150 |
Why?
| | Pseudomonas Phages | 1 | 2019 | 4 | 0.150 |
Why?
| | Epoprostenol | 2 | 2011 | 132 | 0.140 |
Why?
| | Autoimmunity | 1 | 2025 | 930 | 0.140 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2024 | 881 | 0.140 |
Why?
| | Hexosaminidases | 1 | 2017 | 17 | 0.130 |
Why?
| | Bleomycin | 1 | 2019 | 253 | 0.130 |
Why?
| | Mammals | 3 | 2024 | 296 | 0.130 |
Why?
| | Phagocytosis | 1 | 2019 | 296 | 0.130 |
Why?
| | Graft Rejection | 1 | 2020 | 512 | 0.130 |
Why?
| | T-Lymphocytes | 1 | 2025 | 1984 | 0.130 |
Why?
| | Interferon Inducers | 1 | 2016 | 9 | 0.130 |
Why?
| | Sepsis | 1 | 2023 | 643 | 0.120 |
Why?
| | Poly I-C | 1 | 2016 | 58 | 0.120 |
Why?
| | Humans | 30 | 2025 | 144667 | 0.120 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2023 | 2573 | 0.120 |
Why?
| | Aspergillus fumigatus | 1 | 2016 | 26 | 0.120 |
Why?
| | Insulin Resistance | 1 | 2024 | 1241 | 0.120 |
Why?
| | Phosphoproteins | 2 | 2025 | 339 | 0.120 |
Why?
| | Pancreatic Neoplasms | 1 | 2024 | 926 | 0.120 |
Why?
| | Chemokines | 1 | 2016 | 218 | 0.120 |
Why?
| | Vaccines | 1 | 2020 | 388 | 0.110 |
Why?
| | Pulmonary Fibrosis | 1 | 2019 | 393 | 0.110 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2014 | 56 | 0.110 |
Why?
| | Myocardial Reperfusion Injury | 2 | 2006 | 139 | 0.110 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2014 | 153 | 0.110 |
Why?
| | Immunohistochemistry | 3 | 2019 | 1705 | 0.100 |
Why?
| | Pneumonia | 2 | 2017 | 629 | 0.100 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 174 | 0.100 |
Why?
| | Hypertension, Pulmonary | 1 | 2025 | 1948 | 0.100 |
Why?
| | Iron | 1 | 2016 | 358 | 0.100 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2014 | 265 | 0.100 |
Why?
| | Cystic Fibrosis | 1 | 2024 | 1166 | 0.100 |
Why?
| | Allergens | 1 | 2017 | 387 | 0.100 |
Why?
| | Hepatocytes | 1 | 2014 | 221 | 0.100 |
Why?
| | Dinoprostone | 2 | 2011 | 180 | 0.100 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2013 | 75 | 0.100 |
Why?
| | Prediabetic State | 1 | 2015 | 247 | 0.090 |
Why?
| | Drug Antagonism | 1 | 2011 | 9 | 0.090 |
Why?
| | Thromboxanes | 1 | 2011 | 14 | 0.090 |
Why?
| | Toll-Like Receptor 3 | 2 | 2023 | 30 | 0.090 |
Why?
| | Animal Feed | 1 | 2011 | 55 | 0.090 |
Why?
| | Administration, Oral | 2 | 2025 | 851 | 0.080 |
Why?
| | Lipid Metabolism | 1 | 2014 | 524 | 0.080 |
Why?
| | Cyclooxygenase 2 | 1 | 2011 | 166 | 0.080 |
Why?
| | Chemical Fractionation | 1 | 2010 | 29 | 0.080 |
Why?
| | Monocytes | 2 | 2016 | 536 | 0.080 |
Why?
| | Inflammation | 2 | 2023 | 2870 | 0.080 |
Why?
| | Chromatography, Affinity | 1 | 2010 | 80 | 0.080 |
Why?
| | Durapatite | 1 | 2010 | 37 | 0.080 |
Why?
| | Protein Array Analysis | 1 | 2010 | 56 | 0.080 |
Why?
| | Rabbits | 1 | 2011 | 651 | 0.080 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 141 | 0.080 |
Why?
| | Protein Biosynthesis | 1 | 2013 | 455 | 0.080 |
Why?
| | Leukocytes | 3 | 2020 | 294 | 0.080 |
Why?
| | Cholesterol | 1 | 2011 | 404 | 0.070 |
Why?
| | Veins | 1 | 2009 | 69 | 0.070 |
Why?
| | Mice, Inbred BALB C | 3 | 2017 | 1251 | 0.070 |
Why?
| | Cell Proliferation | 3 | 2024 | 2489 | 0.070 |
Why?
| | Cytokines | 1 | 2016 | 2045 | 0.070 |
Why?
| | Thrombin | 1 | 2009 | 167 | 0.070 |
Why?
| | Aorta | 1 | 2011 | 427 | 0.070 |
Why?
| | Transport Vesicles | 1 | 2008 | 22 | 0.070 |
Why?
| | Muscle, Skeletal | 1 | 2018 | 1788 | 0.070 |
Why?
| | ADAM Proteins | 1 | 2008 | 64 | 0.070 |
Why?
| | Receptor, PAR-1 | 1 | 2007 | 17 | 0.070 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2009 | 264 | 0.070 |
Why?
| | Iloprost | 1 | 2007 | 45 | 0.070 |
Why?
| | Thrombosis | 1 | 2011 | 396 | 0.060 |
Why?
| | Biofilms | 2 | 2022 | 301 | 0.060 |
Why?
| | Mice, Inbred NOD | 2 | 2020 | 610 | 0.060 |
Why?
| | Male | 9 | 2025 | 72431 | 0.060 |
Why?
| | Catalase | 1 | 2006 | 133 | 0.060 |
Why?
| | Phospholipase C gamma | 1 | 2025 | 28 | 0.060 |
Why?
| | Exons | 2 | 2020 | 362 | 0.060 |
Why?
| | Receptors, Prostaglandin E | 1 | 2005 | 8 | 0.060 |
Why?
| | Membrane Glycoproteins | 1 | 2008 | 496 | 0.060 |
Why?
| | Tumor Escape | 1 | 2025 | 50 | 0.060 |
Why?
| | Proof of Concept Study | 1 | 2025 | 88 | 0.060 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2007 | 441 | 0.060 |
Why?
| | Liver | 2 | 2013 | 1889 | 0.050 |
Why?
| | HEK293 Cells | 2 | 2020 | 743 | 0.050 |
Why?
| | Asthma | 1 | 2016 | 1774 | 0.050 |
Why?
| | Epithelial Cells | 2 | 2024 | 1106 | 0.050 |
Why?
| | Hydrogen Peroxide | 1 | 2006 | 334 | 0.050 |
Why?
| | Glucuronidase | 1 | 2024 | 26 | 0.050 |
Why?
| | Vascular Resistance | 1 | 2025 | 368 | 0.050 |
Why?
| | Cell Differentiation | 3 | 2017 | 2037 | 0.050 |
Why?
| | Mice, Transgenic | 3 | 2017 | 2184 | 0.050 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2016 | 630 | 0.050 |
Why?
| | Insulin-Secreting Cells | 2 | 2020 | 390 | 0.050 |
Why?
| | Myocardial Ischemia | 1 | 2005 | 285 | 0.050 |
Why?
| | Glucose Tolerance Test | 1 | 2024 | 360 | 0.050 |
Why?
| | Epithelium | 1 | 2024 | 310 | 0.050 |
Why?
| | Endotoxins | 1 | 2023 | 218 | 0.050 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2025 | 426 | 0.050 |
Why?
| | Respiratory System | 1 | 2024 | 151 | 0.050 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2025 | 431 | 0.050 |
Why?
| | Pseudomonas | 1 | 2022 | 33 | 0.050 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2025 | 925 | 0.050 |
Why?
| | Cell Membrane | 1 | 2025 | 706 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2007 | 1468 | 0.040 |
Why?
| | Europe | 1 | 2022 | 419 | 0.040 |
Why?
| | Cell Surface Display Techniques | 1 | 2020 | 13 | 0.040 |
Why?
| | Female | 6 | 2025 | 78304 | 0.040 |
Why?
| | Myocardium | 1 | 2006 | 928 | 0.040 |
Why?
| | Pancreas Transplantation | 1 | 2020 | 70 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2025 | 2033 | 0.040 |
Why?
| | Sputum | 1 | 2022 | 308 | 0.040 |
Why?
| | Solubility | 1 | 2020 | 236 | 0.040 |
Why?
| | Injections | 1 | 2020 | 197 | 0.040 |
Why?
| | NIH 3T3 Cells | 1 | 2020 | 147 | 0.040 |
Why?
| | Insulin | 2 | 2024 | 2502 | 0.040 |
Why?
| | Antigen Presentation | 1 | 2020 | 206 | 0.040 |
Why?
| | Apoptosis | 1 | 2008 | 2397 | 0.040 |
Why?
| | Transplantation, Homologous | 1 | 2020 | 407 | 0.040 |
Why?
| | Glycosylation | 1 | 2020 | 161 | 0.040 |
Why?
| | Wound Healing | 1 | 2022 | 352 | 0.040 |
Why?
| | Endothelium, Vascular | 1 | 2006 | 949 | 0.040 |
Why?
| | Cell Movement | 2 | 2018 | 959 | 0.040 |
Why?
| | Heparin | 1 | 2020 | 243 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2020 | 374 | 0.040 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2019 | 45 | 0.040 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2025 | 915 | 0.040 |
Why?
| | Lung Diseases, Interstitial | 1 | 2025 | 660 | 0.040 |
Why?
| | Streptozocin | 1 | 2018 | 22 | 0.040 |
Why?
| | Mice, Mutant Strains | 1 | 2019 | 300 | 0.040 |
Why?
| | Escherichia coli | 1 | 2023 | 854 | 0.040 |
Why?
| | Phosphorylation | 2 | 2014 | 1704 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2019 | 364 | 0.030 |
Why?
| | Protein Domains | 1 | 2020 | 313 | 0.030 |
Why?
| | Chitin | 1 | 2017 | 9 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2024 | 765 | 0.030 |
Why?
| | Neutrophils | 1 | 2023 | 1118 | 0.030 |
Why?
| | Interferons | 1 | 2019 | 185 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2020 | 4539 | 0.030 |
Why?
| | RNA, Messenger | 3 | 2013 | 2815 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2025 | 3523 | 0.030 |
Why?
| | Chitosan | 1 | 2017 | 39 | 0.030 |
Why?
| | Fibroblasts | 2 | 2016 | 1019 | 0.030 |
Why?
| | Hydrolysis | 1 | 2017 | 198 | 0.030 |
Why?
| | C-Peptide | 1 | 2018 | 190 | 0.030 |
Why?
| | Microscopy, Atomic Force | 1 | 2017 | 132 | 0.030 |
Why?
| | Catalysis | 1 | 2017 | 319 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 835 | 0.030 |
Why?
| | Molecular Weight | 1 | 2017 | 312 | 0.030 |
Why?
| | Aspergillosis | 1 | 2016 | 24 | 0.030 |
Why?
| | Cockroaches | 1 | 2016 | 23 | 0.030 |
Why?
| | Bacteria | 1 | 2023 | 894 | 0.030 |
Why?
| | Molecular Structure | 1 | 2017 | 495 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2017 | 562 | 0.030 |
Why?
| | Lung | 2 | 2022 | 4089 | 0.030 |
Why?
| | Hypersensitivity, Immediate | 1 | 2016 | 41 | 0.030 |
Why?
| | Cross-Linking Reagents | 1 | 2017 | 197 | 0.030 |
Why?
| | Receptors, Leptin | 1 | 2015 | 25 | 0.030 |
Why?
| | Adult | 3 | 2025 | 40489 | 0.030 |
Why?
| | Down-Regulation | 2 | 2008 | 616 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2017 | 321 | 0.030 |
Why?
| | Protein Transport | 1 | 2017 | 437 | 0.030 |
Why?
| | Cattle | 1 | 2017 | 975 | 0.030 |
Why?
| | Immunization | 1 | 2017 | 374 | 0.030 |
Why?
| | Sulfhydryl Compounds | 1 | 2017 | 188 | 0.030 |
Why?
| | Hep G2 Cells | 1 | 2014 | 75 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2019 | 672 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2015 | 203 | 0.030 |
Why?
| | Bronchi | 1 | 2016 | 263 | 0.030 |
Why?
| | Antigens | 1 | 2016 | 347 | 0.030 |
Why?
| | Heart Transplantation | 1 | 2020 | 674 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2019 | 1207 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2018 | 1124 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2014 | 392 | 0.030 |
Why?
| | MAP Kinase Signaling System | 1 | 2015 | 306 | 0.020 |
Why?
| | Protein Sorting Signals | 1 | 2013 | 21 | 0.020 |
Why?
| | Cyclooxygenase 1 | 1 | 2013 | 27 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2017 | 592 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2017 | 477 | 0.020 |
Why?
| | NF-kappa B | 1 | 2017 | 657 | 0.020 |
Why?
| | Stomach | 1 | 2013 | 109 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2024 | 2201 | 0.020 |
Why?
| | DNA, Complementary | 1 | 2013 | 273 | 0.020 |
Why?
| | Multiple Sclerosis | 1 | 2018 | 485 | 0.020 |
Why?
| | Introns | 1 | 2013 | 255 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2013 | 407 | 0.020 |
Why?
| | Hyperglycemia | 1 | 2015 | 374 | 0.020 |
Why?
| | Fatty Acids | 1 | 2014 | 454 | 0.020 |
Why?
| | Binding Sites | 1 | 2014 | 1307 | 0.020 |
Why?
| | Rats | 1 | 2020 | 5570 | 0.020 |
Why?
| | Fluorometry | 1 | 2010 | 18 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2013 | 667 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2025 | 11735 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 828 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 324 | 0.020 |
Why?
| | Obesity | 1 | 2023 | 3070 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2013 | 743 | 0.020 |
Why?
| | Body Mass Index | 1 | 2018 | 2419 | 0.020 |
Why?
| | Prospective Studies | 1 | 2022 | 7994 | 0.020 |
Why?
| | Embryonic Stem Cells | 1 | 2010 | 124 | 0.020 |
Why?
| | Base Sequence | 1 | 2013 | 2177 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2016 | 3109 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 2136 | 0.020 |
Why?
| | Arthritis, Rheumatoid | 1 | 2018 | 1170 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2909 | 0.020 |
Why?
| | U937 Cells | 1 | 2008 | 28 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3603 | 0.020 |
Why?
| | Saphenous Vein | 1 | 2007 | 37 | 0.020 |
Why?
| | Protease Inhibitors | 1 | 2008 | 101 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2847 | 0.020 |
Why?
| | Probability | 1 | 2007 | 309 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2008 | 452 | 0.020 |
Why?
| | Mutation | 1 | 2017 | 4081 | 0.020 |
Why?
| | RNA Interference | 1 | 2008 | 473 | 0.010 |
Why?
| | Adrenergic alpha-Agonists | 1 | 2006 | 28 | 0.010 |
Why?
| | Transfection | 1 | 2008 | 924 | 0.010 |
Why?
| | Isoproterenol | 1 | 2006 | 96 | 0.010 |
Why?
| | RNA, Small Interfering | 1 | 2008 | 631 | 0.010 |
Why?
| | Receptors, Prostaglandin E, EP3 Subtype | 1 | 2005 | 3 | 0.010 |
Why?
| | Adrenergic beta-Agonists | 1 | 2006 | 92 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 973 | 0.010 |
Why?
| | Sodium-Hydrogen Exchangers | 1 | 2005 | 23 | 0.010 |
Why?
| | GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2005 | 20 | 0.010 |
Why?
| | Blotting, Western | 1 | 2007 | 1161 | 0.010 |
Why?
| | Norepinephrine | 1 | 2006 | 196 | 0.010 |
Why?
| | Aged | 1 | 2025 | 25955 | 0.010 |
Why?
| | Mice, Inbred C3H | 1 | 2005 | 252 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2007 | 1301 | 0.010 |
Why?
| | Coronary Circulation | 1 | 2005 | 134 | 0.010 |
Why?
| | Transgenes | 1 | 2005 | 191 | 0.010 |
Why?
| | Myocardial Contraction | 1 | 2006 | 288 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2006 | 1046 | 0.010 |
Why?
| | Protein Kinase C | 1 | 2005 | 250 | 0.010 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2005 | 251 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2007 | 1154 | 0.010 |
Why?
| | Middle Aged | 1 | 2025 | 35971 | 0.010 |
Why?
| | Signal Transduction | 2 | 2007 | 5185 | 0.010 |
Why?
| | Gene Expression | 1 | 2007 | 1476 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2008 | 864 | 0.010 |
Why?
| | Ventricular Function, Left | 1 | 2005 | 536 | 0.010 |
Why?
| | Heart Rate | 1 | 2006 | 853 | 0.010 |
Why?
| | Young Adult | 1 | 2018 | 14122 | 0.010 |
Why?
| | Blood Pressure | 1 | 2006 | 1766 | 0.010 |
Why?
| | Time Factors | 1 | 2008 | 7140 | 0.010 |
Why?
| | Adolescent | 1 | 2016 | 22409 | 0.010 |
Why?
| | Child | 1 | 2016 | 22600 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2005 | 3888 | 0.010 |
Why?
|
|
Kaber's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|